Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Xiaodong WangGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.ORCID 0009-0006-3512-4945
Lewei CaoFaculty of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530011, China.
Jiajun TangFaculty of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530011, China.
Jiagang DengGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.
Erwei HaoGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.ORCID 0000-0001-7394-6022
Gang BaiState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.ORCID 0000-0001-9161-2173
Pei Ling TangDepartment of Bioscience, Faculty of Applied Sciences, Tunku Abdul Rahman University of Management and Technology, Kuala Lumpur 50250, Malaysia.ORCID 0000-0002-2096-6617
Jieyi YangGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.
Huaying LiGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.
Lihao YaoGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.
Cuiwei HeGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.
Xiaotao HouGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530011, China.
Funding
the 2020 Annual Guangxi Key Laboratory for the Study of Efficacy of Chinese Herbal Medicine Operating Subsidy Project 20-065-38the Cao Le-wei - Admissions and Employment Office - Study on the Pharmacological Mechanisms of Corn Stover Extract in Treating Hyperlipidemia in Rats XDC23046the "GuiPai" Traditional Chinese Medicine Heritage and Innovation Team project 2022A005the Tang Jiajun - Admissions and Employment Office - The Development and Research of Corn Stover Functional Beverage for Reducing Blood Lipids (College Student Innovation Project) XDC23221
6 · The paper itself
Abstract
Corn (
Indexed as
chemical compositioncorn wastesdyslipidemiahyperlipidemiamechanism studyZea mays L.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Research on the Mechanism and Material Basis of Corn ( · full record | OpenQuestion